ARSMX
Price
$10.44
Change
+$0.11 (+1.06%)
Updated
Jul 24 closing price
Net Assets
343.04M
VISVX
Price
$58.57
Change
+$0.51 (+0.88%)
Updated
Jul 24 closing price
Net Assets
67.78B
Interact to see
Advertisement

ARSMX vs VISVX

ARSMX vs VISVX Comparison Chart in %
View a ticker or compare two or three
VS
ARSMX vs. VISVX commentary
Jul 26, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARSMX is a Hold and VISVX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VISVX has more cash in the bank: 67.8B vs. ARSMX (343M). VISVX pays higher dividends than ARSMX: VISVX (1.66) vs ARSMX (0.22). ARSMX was incepted earlier than VISVX: ARSMX (19 years) vs VISVX (28 years). ARSMX (1.28) is less costly to investors than VISVX (0.19). ARSMX is a more actively managed with annual turnover of: 36.00 vs. VISVX (25.00). VISVX has a lower initial minimum investment than ARSMX: VISVX (0) vs ARSMX (2000). VISVX annual gain was more profitable for investors over the last year : 21.24 vs. ARSMX (5.59). VISVX return over 5 years is better than : 47.71 vs. ARSMX (9.71).
ARSMXVISVXARSMX / VISVX
Total Expense Ratio1.280.19674%
Annual Report Gross Expense Ratio1.280.19674%
Fund Existence19 years28 years-
Gain YTD9.54915.55361%
Front LoadN/AN/A-
Min. Initial Investment20000-
Min. Initial Investment IRAN/AN/A-
Net Assets343M67.8B1%
Annual Yield % from dividends0.221.6613%
Returns for 1 year5.5921.2426%
Returns for 3 years15.0043.8234%
Returns for 5 years9.7147.7120%
Returns for 10 years47.03131.8636%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NSP48.350.37
+0.77%
Insperity
KYMR110.570.19
+0.17%
Kymera Therapeutics
FGBIP19.41-0.42
-2.12%
First Guaranty Bancshares
MCRB4.97-0.27
-5.07%
Seres Therapeutics Inc
CTEV21.61-1.66
-7.13%
Claritev Corporation